Delivery Order SPE2DB22D2211-SPE2DB25FSEWW
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of INLYTA 5 mg tablets (60-count) valued at $11.9K under a firm fixed-price contract type. This delivery order, issued on October 22, 2025, with an ultimate completion date of November 13, 2025, represents a non-competitive set-aside award for pharmaceutical procurement to support federal medical supply needs. The award is performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of INLYTA 5 mg tablets (60-count units) with a ceiling value of $11,895.72. This firm fixed price delivery order, with an ultimate completion date of September 8, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement...
- The Defense Logistics Agency awarded a $23.79K delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of INLYTA 5 MG tablets (60-count units). This firm fixed-price, non-competitive delivery order is scheduled for completion by October 16, 2025, with performance at the contractor's Conshohocken, Pennsylvania facility. As a child delivery order, this award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support...
- The Defense Logistics Agency awarded a $23,847.20 delivery order to AmerisourceBergen Drug Corp for 180 tablets of INLYTA 1 mg, a pharmaceutical product used in cancer treatment. This firm fixed-price delivery order, issued on August 5, 2025, with an ultimate completion date of August 26, 2025, represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $12,536.26 to AmerisourceBergen Drug Corp for 60 tablets of INLYTA 5 mg, a pharmaceutical product used in cancer treatment. This non-set-aside, firm fixed price delivery order was awarded on November 12, 2025, with an ultimate completion date of December 4, 2025. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of INLYTA 5 mg tablets (60-count units) with a ceiling value of $11,895.72. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made through competitive procurement with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $23,847.20 to supply 180 tablets of INLYTA 1 mg, a pharmaceutical product for cancer treatment. This non-competitive, firm fixed-price delivery order was awarded on June 5, 2025, with a completion date of June 27, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $11.9K to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Inlyta 5 mg tablets (60-count units). The contract is firm fixed price with an ultimate completion date of October 2, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order valued at $11,895.72 by the Defense Logistics Agency on July 22, 2025, for the supply of INLYTA 5 mg tablets in quantities of 60 units. The contract, which carries a firm fixed-price structure with an ultimate completion date of August 12, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Inlyta 5 mg tablets (60-count units) with a ceiling value of $11,895.72. This non-set-aside contract, awarded on July 21, 2025, utilizes firm fixed pricing and is scheduled for completion by August 11, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSEWWDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $71,374.32 to supply 60 tablets of INLYTA 5 mg, a pharmaceutical product, with performance at the company's Conshohocken, Pennsylvania facility. The award, issued on September 12, 2025, carries a completion date of October 3, 2025, and utilizes firm fixed pricing without any set-aside designation. This delivery order represents a competitive award to the prime contractor under an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds a substantial Indefinite Delivery Contract with the DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as the primary vehicle enabling the company to fulfill federal pharmaceutical procurement needs across military healthcare systems and related government agencies. The company's extensive federal contracting portfolio demonstrates its established capability to deliver pharmaceutical products and medical supplies competitively to support defense and veteran healthcare requirements globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $71.4k | 9/12/25 |